Advancements in Biologic Therapy and Axial Spondyloarthritis Classification

This chapter explores the latest developments in biologic therapies for axial spondyloarthritis, focusing on the significance of biomarkers and the benefits of therapy combinations. It highlights new definitions and classification criteria from recent research, emphasizing the importance of early recognition and refined criteria for better patient outcomes.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app